Related Experiment Video
Updated: Aug 6, 2026

18:30
Rat Mesentery Angiogenesis Assay
Published on: June 18, 2011
Detecting the Effects of Angiogenic Therapy: How Do We Measure Efficacy?
1Division of Cardiovascular Disease, Department of Internal Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA.
Summary
This review analyzes methods to detect the effects of angiogenic interventions on heart blood flow and function. It evaluates techniques for measuring myocardial blood flow and assessing left ventricular function in clinical trials.
Area of Science:
- Cardiovascular Research
- Biomedical Engineering
- Regenerative Medicine
Background:
- Angiogenic interventions aim to improve blood supply to the heart.
- Accurate assessment of efficacy is crucial for clinical translation.
- Existing methods require evaluation for reliability and clinical feasibility.
Purpose of the Study:
- To review and analyze methods for detecting the effects of angiogenic interventions.
- To compare animal-based and clinical techniques for assessing myocardial blood flow and left ventricular function.
- To provide recommendations for end points in angiogenic trials.
Main Methods:
- Review of animal-based methods for myocardial blood flow and angiogenesis detection.
- Analysis of clinically feasible end points: perfusion imaging (radionuclide, PET, MRI, EBCT), myocardial contrast echocardiography.
- Discussion of indirect methods assessing left ventricular function and reproducibility.
Main Results:
- Strengths and weaknesses of various imaging techniques for assessing angiogenic intervention efficacy are analyzed.
- Reproducibility of serial measurements for indirect functional assessments is considered.
- Comparison of direct blood flow measurements versus indirect functional assessments.
Conclusions:
- Specific recommendations for efficacy and effectiveness end points in angiogenic trials are provided.
- Selection of appropriate end points is critical for evaluating angiogenic therapies.
- The review guides the choice of optimal methods for future clinical studies.
Related Concept Videos
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

